Westpac Banking Corp
TXG icon

Westpac Banking Corp’s 10x Genomics TXG Stock Holding History

Westpac Banking Corp’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.63M Buy
+40,185
New +$2.35M 0.22% 97
2022
Q4 		– Sell
-66,900
Closed -$1.91M – 792
2022
Q3 		$1.91M Buy
+66,900
New +$2.55M 0.03% 512
2022
Q2 		– Sell
-5,456
Closed -$415K – 848
2022
Q1 		$415K Hold
5,456
– – ﹤0.01% 791
2021
Q4 		$813K Buy
5,456
+426
+8% +$65.3K 0.01% 723
2021
Q3 		$732K Hold
5,030
– – 0.01% 763
2021
Q2 		$985K Hold
5,030
– – 0.01% 756
2021
Q1 		$910K Hold
5,030
– – 0.01% 708
2020
Q4 		$712K Buy
+5,030
New +$730K 0.01% 781

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Quantinno Capital Management
Quantinno Capital Management New York $106B AUM 29.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Westpac Banking Corp's TXG Position: Q3 2026 in Review

Westpac Banking Corp opened a new position in 10x Genomics (TXG) in Q3 2026: 40,185 shares worth $3.63M. The stake represents 0.22% of the portfolio and ranks #97 among its holdings. This is a return to the name: Westpac Banking Corp previously reported a position in TXG as recently as Q3 2022.

Westpac Banking Corp first reported a position in TXG in Q4 2020 and has held it in 8 quarters since. 377 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Westpac Banking Corp held 40,185 shares of 10x Genomics worth $3.63M as of Q3 2026.
  • 10x Genomics was a new Westpac Banking Corp position in Q3 2026.
  • 10x Genomics made up 0.22% of Westpac Banking Corp's portfolio in Q3 2026, its #97 holding.
  • Westpac Banking Corp first reported a position in 10x Genomics in Q4 2020 and has held it in 8 quarters since.
  • 377 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Westpac Banking Corp's 13F filing for Q3 2026, filed 10 Nov 2026.